Literature DB >> 18372382

Patients' experiences of carcinoma of unknown primary site: dealing with uncertainty.

Lucy Boyland1, Carol Davis.   

Abstract

UNLABELLED: It is generally acknowledged that patients may find it particularly hard to accept a cancer diagnosis if the primary origin cannot be identified. However, there is very little research exploring this. AIMS: This is an exploratory mixed-method, largely qualitative, pilot study to explore patients' understanding of carcinoma of unknown primary site, any concerns they may have and to assess their quality of life.
METHODS: Ten patients were recruited and nine completed semi-structured interviews and McGill quality of life questionnaires. Thematic analysis was used in conjunction with demographic data and quality of life scores.
RESULTS: Six main themes were identified. These were--poor understanding, struggling with uncertainty/contrasting with stoical acceptance, undergoing multiple investigations, inability to treat, healthcare professionals not having the answers and difficulty explaining to others.
CONCLUSION: Many patients find the uncertainty difficult and would welcome more opportunity to ask questions and learn of others' experiences.

Entities:  

Mesh:

Year:  2008        PMID: 18372382     DOI: 10.1177/0269216307085341

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  8 in total

1.  Nationwide survey on family caregiver-perceived experiences of patients with cancer of unknown primary site.

Authors:  Kyoko Ishida; Kazuki Sato; Hirokazu Komatsu; Tatsuya Morita; Tatsuo Akechi; Megumi Uchida; Kento Masukawa; Naoko Igarashi; Yoshiyuki Kizawa; Satoru Tsuneto; Yasuo Shima; Mitsunori Miyashita; Shoko Ando
Journal:  Support Care Cancer       Date:  2022-04-28       Impact factor: 3.603

2.  Development and Validation of a Novel Nomogram for Individualized Prediction of Survival in Cancer of Unknown Primary.

Authors:  Kanwal Raghav; Hyunsoo Hwang; Alexandre A Jácome; Eric Bhang; Anneleis Willett; Ryan W Huey; Nishat P Dhillon; Jignesh Modha; Brandon Smaglo; Aurelio Matamoros; Jeannelyn S Estrella; Justin Jao; Michael J Overman; Xuemei Wang; F Anthony Greco; Jonathan M Loree; Gauri R Varadhachary
Journal:  Clin Cancer Res       Date:  2021-04-15       Impact factor: 12.531

3.  Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial.

Authors:  Shernan G Holtan; Preston D Steen; Nathan R Foster; Charles Erlichman; Fabiola Medeiros; Matthew M Ames; Stephanie L Safgren; David L Graham; Robert J Behrens; Matthew P Goetz
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

4.  'This wound has spoilt everything': emotional capital and the experience of surgical site infections.

Authors:  Brian Brown; Judith Tanner; Wendy Padley
Journal:  Sociol Health Illn       Date:  2014-11

5.  Serous Cystadenocarcinoma Arising in Presumed Vitelline Duct Remnant: A Case Report and Implications in the Management of Cancer of Unknown Primary.

Authors:  Li Lei; Jeremy K Deisch
Journal:  Case Rep Pathol       Date:  2016-11-24

6.  Uncertainty and the unmet informational needs of patients with cancer of unknown primary (CUP): a cross-sectional multi-site study.

Authors:  Lisa Guccione; Krista Fisher; Linda Mileshkin; Richard Tothill; David Bowtell; Stephen Quinn; Anna DeFazio; Chris S Karapetis; Nicholas Wilcken; Madhu Singh; Christopher Steer; Bo Gao; Mark Warren; Ian M Collins; Narayan Karanth; Cindy Bryant; Penelope Schofield
Journal:  Support Care Cancer       Date:  2022-07-09       Impact factor: 3.359

7.  Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities.

Authors:  D Urban; A Rao; M Bressel; Y R Lawrence; L Mileshkin
Journal:  Br J Cancer       Date:  2013-07-16       Impact factor: 7.640

8.  Differences in experiences of care between patients diagnosed with metastatic cancer of known and unknown primaries: mixed-method findings from the 2013 cancer patient experience survey in England.

Authors:  Richard Wagland; Mike Bracher; Allison Drosdowsky; Alison Richardson; John Symons; Linda Mileshkin; Penny Schofield
Journal:  BMJ Open       Date:  2017-09-27       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.